World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02352194
Date of registration: 20/01/2015
Prospective Registration: No
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis REHABSEP
Scientific title: Observational Study of the Physical Capacity of Patients With Multiple Sclerosis and Evaluation of the Effects of Usual Rehabilitation in the Day Hospital
Date of first enrolment: July 2014
Target sample size: 60
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02352194
Study type:  Observational
Study design:  Observational Model: Cohort  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Djamel Bensmail, MD, PhD
Address: 
Telephone: +33147107060
Email: djamel.bensmail@rpc.aphp.fr
Affiliation: 
Name:     Djamel Bensmail, MD,PhD
Address: 
Telephone: +33147107060
Email: djamel.bensmail@rpc.aphp.fr
Affiliation: 
Name:     Raphael Zory, PhD
Address: 
Telephone:
Email:
Affiliation:  LAMHESS Laboratory, Faculty of Sports Science, 06205 Nice, France
Name:     Djamel Bensmail, MD,PhD
Address: 
Telephone:
Email:
Affiliation:  Physical and Rehabilitation Medicine department, Raymond Poincaré Hospital,
Name:     Sophie Hameau
Address: 
Telephone:
Email:
Affiliation:  Physical and Rehabilitation Medicine department, Raymond Poincaré Hospital,
Key inclusion & exclusion criteria

Inclusion Criteria:

- Multiple Sclerosis with EDSS = 6 (Expanded Disability Status Scale)

- Patient = 18 years old

- Patient able to comply with the recommended monitoring

- No relapse within the last three months

- More than six months elapsed since last medical care in day hospital

- No recent modification (six month) of medications for MS

- More than three months elapsed since last change of associated treatments (Fampyra,
botulinum toxin)

Exclusion Criteria:

- Patients under any form of guardianship or curatorship

- Breastfeeding

- Orthopedic complications with repercussions on walking activities

- No affiliation to a social security scheme (beneficiary or assignee)



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Multiple Sclerosis (MS)
Intervention(s)
Other: Rehabilitation
Primary Outcome(s)
Assessment of the strength and fatigue [Time Frame: Within 10 weeks from the start of the rehabilitation program]
Secondary Outcome(s)
Assessment of Quality of Life with SEP-59 Scale [Time Frame: Within 10 weeks from the start of the rehabilitation]
6 minutes walking test [Time Frame: Within 10 weeks from the start of the rehabilitation program]
Assessment of Spasticity with the Modified Ashworth Scale (MAS), [Time Frame: Within 10 weeks from the start of the rehabilitation program]
Assessment of the balance of patients [Time Frame: Within 10 weeks from the start of the rehabilitation program]
10 meters Walk test [Time Frame: Within 10 weeks from the start of the rehabilitation]
Assessment of the balance of patients [Time Frame: Within 10 weeks from the start of the rehabilitation]
Time to ascend and descend stairs [Time Frame: Within 10 weeks from the start of the rehabilitation]
Assessment of Strength with the Medical Research Council (MRC), [Time Frame: Within 10 weeks from the start of the rehabilitation]
Evaluation of aerobic capacity during an effort test [Time Frame: Within 10 weeks from the start of the rehabilitation program]
Timed up and go test [Time Frame: Within 10 weeks from the start of the rehabilitation]
Secondary ID(s)
14-REHABSEP
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history